(1R,4S,5R,6R)-N5-(4-Bromophenyl)-N6-(4-(piperidin-1-yl)butyl)spiro[bicyclo[2.2.1]heptane-7,1'-cyclopropan]-2-ene-5,6-dicarboxamide

Catalog No. :
ACRTXT249
CAS No. :
1256273-37-6
Molecular Formula :
C26H34BrN3O2
Molecular Weight :
500.48

IUPAC Name:(1R,4S,5R,6R)-N5-(4-bromophenyl)-N6-(4-(piperidin-1-yl)butyl)spiro[bicyclo[2.2.1]heptane-7,1'-cyclopropan]-2-ene-5,6-dicarboxamide

(1R,4S,5R,6R)-N5-(4-Bromophenyl)-N6-(4-(piperidin-1-yl)butyl)spiro[bicyclo[2.2.1]heptane-7,1'-cyclopropan]-2-ene-5,6-dicarboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1R,4S,5R,6R)-N5-(4-Bromophenyl)-N6-(4-(piperidin-1-yl)butyl)spiro[bicyclo[2.2.1]heptane-7,1'-cyclopropan]-2-ene-5,6-dicarboxamide
IUPAC Name(1R,4S,5R,6R)-N5-(4-bromophenyl)-N6-(4-(piperidin-1-yl)butyl)spiro[bicyclo[2.2.1]heptane-7,1'-cyclopropan]-2-ene-5,6-dicarboxamide
Molecular FormulaC26H34BrN3O2
Molecular Weight500.48
SMILESO=C(NCCCCN1CCCCC1)[C@H]1[C@H](C(=O)NC2=CC=C(Br)C=C2)[C@@H]2C=C[C@H]1C21CC1
InChI KeyKBXVDFCRVPEDDY-KAOXLYBCSA-N
Synonym(1R,4S,5R,6R)-N5-(4-Bromophenyl)-N6-(4-(piperidin-1-yl)butyl)spiro[bicyclo[2.2.1]heptane-7,1'-cyclopropan]-2-ene-5,6-dicarboxamide
CAS No.1256273-37-6

Synthetic Route by SureRoute

1. ACRTXT249 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRTXT249 route product structure diagram
    ACRTXT2491256273-37-6
Inquiry

2. ACRTXT249 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRTXT249 route product structure diagram
    ACRTXT2491256273-37-6
Inquiry

Comments (0)